Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

'Anti dementia' shake goes on sale


A brain-boosting milkshake that is said to reduce symptoms of early Alzheimer’s goes on sale in the UK today.

Souvenaid, which costs £3.49 per 125 ml bottle, contains a cocktail of nutrients needed to build new connections in the brain.

Its makers, Nutricia, claim the once-a-day product has been clinically shown to improve memory in mildly-affected patients.

But Professor Clive Ballard, director of research at the Alzheimer’s Society, urged people to spend their money elsewhere.

He said: “People shouldn’t get excited that an off-the-shelf drink is going to transform the lives of people with dementia.”

Around 800,000 people in the UK are living with dementia, more than half with Alzheimer’s disease.

As the population ages, the number of dementia sufferers is expect to soar to 1.7m by 2051.

Souvenaid is said to be the result of more than a decade of research into the nutritional needs of people with early Alzheimer’s.

A key feature of the disease is the loss of synapses, or connections in the brain, which are vital to memory.

People with Alzheimer’s are known to lack certain nutrients necessary for synapse-building, it is claimed.

Souvenaid, which comes in vanilla and strawberry flavours, is designed to boost levels of these nutrients. It contains omega-3 fatty acids, uridine, which is important for metabolism, and choline, used to make a vital nerve-signalling chemical. Other nutrients in the milk-based drink include phospholipids, a component of cell membranes, and B vitamins.

In a randomly controlled clinical trial involving 259 patients from six European countries, Souvenaid produced statistically significant improvements in episodic memory over 24 weeks.

Professor Ballard said: “While past studies of this product have showed some benefits for memory, there is no evidence that it has an effect on other aspects of thinking or everyday life and there was also no benefit on other symptoms of dementia.”





Readers' comments (2)

  • tinkerbell


    Unsuitable or offensive? Report this comment

  • more expensive than a cup of tea or coffee.

    would drugs like ritalin or the brain enhancing drugs college students use in the USA work?

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.